Relmada Therapeutics Inc (RLMD)
3.84
+0.02
(+0.52%)
USD |
NASDAQ |
May 08, 15:00
Relmada Therapeutics Accounts Payable (Quarterly): 3.506M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.506M |
September 30, 2023 | 2.857M |
June 30, 2023 | 4.854M |
March 31, 2023 | 4.422M |
December 31, 2022 | 5.262M |
September 30, 2022 | 10.43M |
June 30, 2022 | 7.540M |
March 31, 2022 | 10.67M |
December 31, 2021 | 11.19M |
September 30, 2021 | 12.71M |
June 30, 2021 | 10.46M |
March 31, 2021 | 8.083M |
December 31, 2020 | 8.346M |
September 30, 2020 | 0.7286M |
June 30, 2020 | 0.9652M |
March 31, 2020 | 1.103M |
September 30, 2019 | 1.266M |
June 30, 2019 | 0.9244M |
March 31, 2019 | 1.080M |
December 31, 2018 | 0.3589M |
September 30, 2018 | 1.019M |
June 30, 2018 | 0.7654M |
Date | Value |
---|---|
March 31, 2018 | 1.092M |
December 31, 2017 | 0.2861M |
September 30, 2017 | 0.3505M |
June 30, 2017 | 0.5296M |
March 31, 2017 | 0.3354M |
December 31, 2016 | 0.3072M |
September 30, 2016 | 0.6717M |
June 30, 2016 | 1.260M |
March 31, 2016 | 0.7442M |
December 31, 2015 | 1.688M |
September 30, 2015 | 1.15M |
June 30, 2015 | 0.8353M |
March 31, 2015 | 0.3904M |
December 31, 2014 | 0.97M |
September 30, 2014 | 0.6247M |
February 28, 2014 | 0.0412M |
November 30, 2013 | 0.0403M |
August 31, 2013 | 0.0337M |
May 31, 2013 | 0.0258M |
February 28, 2013 | 0.012M |
August 31, 2012 | 0.007M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.7286M
Minimum
Sep 2020
12.71M
Maximum
Sep 2021
5.850M
Average
5.058M
Median
Accounts Payable (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 3.543M |
Lifecore Biomedical Inc | 22.14M |
Harrow Inc | 21.42M |
Corvus Pharmaceuticals Inc | 1.525M |
Aquestive Therapeutics Inc | 8.926M |